Jan 2012: PINC Sector Report – Pharma Monthly Update

Please Share:: India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

PINC Sector Report – Pharma Monthly Update

NEWS ROUNDUP FOR THE MONTH-DECEMBER

DOMESTIC:

·         Ranbaxy launches generic version of Lipitor with a profit sharing deal with Teva·         Ranbaxy launches authorized generic version of Caduet
·         Ranbaxy signs consent decree with the USFDA
·         Ranbaxy Labs' consent decree could engulf multiple facilities
·         Dr Reddy's shifts drug discovery focus away from heart diseases
·         Dr Reddy's offers VRS to Mexico arm employees
·         Dr Reddy's splits its marketing division, Acura to resurrect its ailing domestic business
·         Dr Reddy's plans Lipitor generic launch in June
·         Dr Reddy's launches pain treatment cream 'Supamove' in India
·         Lupin's generic Fortamet launch is prohibited due to grant of Preliminary injunction
·         Lupin eyes USD300mn revenues from Japan in the next 2 years
·         Lupin to replicate Japan model for expansion in various markets
·         Lupin receives final approval for Tricor
·         Glenmark to initiate filing for Crofelemer as Salix submits NDA
·         Glenmark gets DCGI nod for phase III trials of Crofelemer in India
·         Sun Pharma's Dilip Shanghvi buys 3.5% stake in Natco Pharma
·         IsZo Capital Management LP, minority shareholder of Taro rejects Sun Pharma's Taro acquisition proposal
·         Cadila acquires Biochem Pharmaceuticals
·         Orchid Chemicals gets USD1.5mn milestone payment from Merck
·         Orchid Chemicals to raise USD100mn ECBs to redeem its outstanding FCCBs
·         Clinigene, subsidiary of Biocon enters into collaborative clinical research services agreement with Pacific Biomarkers
·         Opto Circuits US arm supplies cardiac devices to Australian soccer clubs

 

GLOBAL:

·         Teva failed to win US clearance for the first OTC emergency contraceptive·         WHO approves Mylan generic HIV drugs for use in developing world
·         Mylan wins ruling, overturning generic Doryx antibiotic ban
·         Amgen plans to team up with Watson on generics
·         GSK to sell non core OTC brands in US and Canada to Prestige Brands Holdings for USD660mn

INDUSTRY:

• 500 drug companies told to pay Rs40bn penalty for over charging